Skip to main content

Want a detailed portfolio tracker?

Polyrizon (PLRZ) P/E (2024 - 2026)

Polyrizon (PLRZ) P/E from Oct 29, 2024 to Jul 21, 2026. The TTM Polyrizon (PLRZ) P/E is -6.52. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Polyrizon (PLRZ)

YearP/EChange
2026-6.52+58.89%
2025-4.10-99.82%
2024-2.31KN/A

Comparison Polyrizon (PLRZ) P/E with competitors

Polyrizon (PLRZ) P/E is -6.52.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.03%
NBYStablecoin Development Corp0.00-100.07%
ENLVEnlivex Ltd0.07-101.15%
FGENFibroGen Inc0.24-103.68%
CHRSCoherus Biosciences Inc0.85-113.02%
FBIOFortress Biotech Inc0.95-114.57%
ORMPOramed Pharmaceuticals Inc1.50-123.07%
AGENAgenus Inc3.01-146.19%
INVAInnoviva Inc3.15-148.41%
VXRTVaxart Inc3.55-154.48%
CRMDCorMedix Inc3.63-155.69%
CVACCureVac N.V.4.45-168.23%
GLPGGalapagos NV4.86-174.58%
SRPTSarepta Therapeutics Inc4.88-174.93%
ABEOAbeona Therapeutics Inc5.39-182.69%
ABUSArbutus Biopharma Corp5.60-185.88%
ZVRAZevra Therapeutics Inc5.89-190.36%
SPROSpero Therapeutics Inc6.23-195.60%
CGENCompugen Ltd6.31-196.91%
RIGLRigel Pharmaceuticals6.87-205.47%
SLXNSilexion Therapeutics Corp7.30-211.98%
OMEROmeros Corporation9.26-242.11%
AUPHAurinia Pharmaceuticals Inc9.58-247.11%
PLXProtalix BioTherapeutics Inc10.89-267.16%
ACADAcadia Pharmaceuticals Inc11.73-280.01%
TBPHTheravance Biopharma Inc12.26-288.20%
ADMAAdma Biologics Inc12.42-290.60%
HRMYHarmony Biosciences Holdings Inc13.82-312.12%
SABSSAB Biotherapeutics Inc14.14-316.97%
NAGENiagen Bioscience Inc14.82-327.43%
INCYIncyte Corp15.82-342.85%
REGNRegeneron Pharmaceuticals Inc15.86-343.37%
PBYIPuma Biotechnology Inc17.32-365.77%
CPRXCatalyst Pharmaceuticals Inc17.44-367.66%
EXELExelixis Inc17.54-369.18%
TGTXTG Therapeutics Inc18.97-391.10%
MDXGMimedx Group Inc20.55-415.45%
XOMAXOMA Royalty Corp22.87-451.10%
ARGXArgen X SE24.30-472.94%
CTMXCytomX Therapeutics Inc24.82-480.97%
XOMAOXOMA Royalty Corp25.34-489.01%
HALOHalozyme Therapeutics Inc25.62-493.29%
XOMAPXOMA Royalty Corp25.67-494.00%
VRTXVertex Pharmaceuticals Inc27.99-529.68%
RPRXRoyalty Pharma plc - Class A28.69-540.32%
SLNOSoleno Therapeutics Inc29.02-545.35%
ASNDAscendis Pharma A/S30.09-561.77%
LGNDLigand Pharmaceuticals Inc - Class B37.91-681.90%
APLSApellis Pharmaceuticals Inc39.02-698.92%
BMRNBiomarin Pharmaceutical Inc42.21-747.90%
KRYSKrystal Biotech Inc45.34-795.96%
ONCBeiGene Ltd69.54-1167.35%
PHARPharming Group N.V.75.03-1251.54%
TECHBio-Techne Corp101.96-1664.93%
VCELVericel Corp109.92-1787.15%
ALNYAlnylam Pharmaceuticals Inc117.96-1910.61%
GMABGenmab140.29-2253.28%
TLXTelix Pharmaceuticals Ltd162.15-2588.83%
CORTCorcept Therapeutics Inc212.86-3367.08%